Applied Dna Scns (APDN)

Jan 10, 2025, 9:00 AM EST - 7 days ago

Applied DNA Completes Buildout of GMP Facility for LineaDNA IVT Templates

Jan 8, 2025, 4:30 PM EST - 9 days ago

Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter

Dec 18, 2024, 9:00 AM EST - 4 weeks ago

Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA

Dec 17, 2024, 4:05 PM EST - 4 weeks ago

Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines

Dec 16, 2024, 10:00 AM EST - 4 weeks ago

Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out

Oct 30, 2024, 7:15 AM EDT - 2 months ago

Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement

Oct 15, 2024, 10:30 AM EDT - 3 months ago

Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16

Sep 18, 2024, 9:00 AM EDT - 4 months ago

Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement

Sep 17, 2024, 9:15 AM EDT - 4 months ago

Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 3rd Annual mRNA Process Development & Manufacturing Summit

Sep 17, 2024, 9:00 AM EDT - 4 months ago

Applied DNA Receives Linea DNA Follow-on Order from Global Manufacturer of IVDs for Cancer Diagnostic Application

Sep 11, 2024, 9:00 AM EDT - 4 months ago

Applied DNA Launches Mpox Clade I and Clade II Testing Service

Sep 4, 2024, 9:00 AM EDT - 4 months ago

Applied DNA Selected by LRQA for Isotopic Testing Pilot Project in Pakistan

Aug 23, 2024, 1:19 PM EDT - 5 months ago

Why Is Diagnostic Tests Provider Applied DNA Sciences Stock Trading Higher On Friday?

Aug 23, 2024, 9:00 AM EDT - 5 months ago

Applied DNA Submits Validation Package to New York State Department of Health to Expand Linea Mpox Virus 1.0 Assay to Mpox Clade I

Aug 19, 2024, 3:25 PM EDT - 5 months ago

Applied DNA To Submit Application to New York State Department of Health to Expand Intended Use of Linea Mpox Virus 1.0 Assay to Mpox Clade I

Aug 11, 2024, 12:29 PM EDT - 5 months ago

Applied DNA Sciences, Inc. (APDN) Q3 2024 Earnings Call Transcript

Aug 8, 2024, 4:10 PM EDT - 5 months ago

Applied DNA Announces Third Quarter Fiscal Year 2024 Financial Results

Aug 7, 2024, 8:00 AM EDT - 5 months ago

Applied DNA to Report Third Quarter Fiscal 2024 Financial Results on Thursday, August 8, 2024

Jul 29, 2024, 11:57 AM EDT - 6 months ago

CORRECTING AND REPLACING: Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Annual mRNA-based Therapeutics Summit

Jul 29, 2024, 11:10 AM EDT - 6 months ago

Applied DNA to Showcase Linea IVT as a High-yield, dsRNA-Mitigated Platform for the GMP Manufacture of RNA at the 4th Presentation Annual mRNA-based Therapeutics Summit

Jul 25, 2024, 9:00 AM EDT - 6 months ago

Applied DNA Enters into Multi-Year Commercialization Agreement with Indus Group for Large-Scale Implementation of CertainT Cotton Traceability

Jul 18, 2024, 10:00 AM EDT - 6 months ago

U.S. Defense Logistics Agency Exercises 1-Year Option Period in Applied DNA Counterfeit Mitigation Contract

Jun 20, 2024, 9:15 AM EDT - 7 months ago

Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics

MRVI

Jun 18, 2024, 9:00 AM EDT - 7 months ago

Applied DNA Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic (PGx) Testing

Jun 13, 2024, 9:00 AM EDT - 7 months ago

Applied DNA Receives Approval for TR8(TM) Pharmacogenomic (PGx) Testing Service from New York State Department of Health

Jun 10, 2024, 1:14 PM EDT - 7 months ago

Time to Play 5 Top-Ranked Stocks With Rising P/E?

AMC HCAT XGN YOU

Jun 5, 2024, 9:00 AM EDT - 8 months ago

Applied DNA Announces Notice of Allowance for U.S. Patent Covering Fundamental Aspect of its Linea(TM) IVT Platform

May 13, 2024, 8:55 AM EDT - 8 months ago

Institute of Hematology and Blood Transfusion (Prague) to Present on Successful Use of Applied DNA's Linea DNATM for the Non-Viral Manufacture of CAR T-Cell Therapy for Refractory AML

May 10, 2024, 4:05 PM EDT - 9 months ago

Applied DNA Announces Second Quarter Fiscal Year 2024 Financial Results

Apr 25, 2024, 9:00 AM EDT - 9 months ago

Applied DNA Awarded Contract by HDT Bio For Rapid Vaccine Development Program

Apr 22, 2024, 4:05 PM EDT - 9 months ago

Applied DNA Announces 1-For-20 Reverse Stock Split

Mar 18, 2024, 9:00 AM EDT - 10 months ago

Applied DNA Enters into Agreement with Alphazyme for Scale-Up Manufacturing of its Proprietary Linea(TM) RNAP, Progresses Towards GMP Linea(TM) IVT Production Start

Mar 14, 2024, 10:00 AM EDT - 11 months ago

Applied DNA to Showcase Linea(TM) DNA and Linea(TM) IVT Platforms at 24th Annual World Vaccine Congress

Feb 9, 2024, 1:32 PM EST - 1 year ago

Applied DNA Sciences, Inc. (APDN) Q1 2024 Earnings Call Transcript

Feb 8, 2024, 4:05 PM EST - 1 year ago

Applied DNA Announces First Quarter Fiscal Year 2024 Financial Results

Feb 5, 2024, 1:00 PM EST - 1 year ago

Applied DNA to Report First Quarter Fiscal 2024 Financial Results on Thursday, February 8, 2024

Feb 2, 2024, 4:15 PM EST - 1 year ago

Applied DNA Announces Closing of $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Jan 31, 2024, 8:00 AM EST - 1 year ago

Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Dec 14, 2023, 8:00 AM EST - 1 year ago

Applied DNA Announces Joint Development Agreement to Integrate Linea(TM) IVT Platform into CDMO Kudo Biotechnology's mRNA Manufacturing Workflow

Dec 8, 2023, 3:13 PM EST - 1 year ago

Applied DNA Sciences, Inc. (APDN) Q4 2023 Earnings Call Transcript

Dec 7, 2023, 4:05 PM EST - 1 year ago

Applied DNA Announces Fourth Quarter Fiscal Year 2023 Financial Results

Dec 5, 2023, 8:30 AM EST - 1 year ago

Applied DNA to Report Fiscal 2023 Fourth Quarter and Year End Financial Results on December 7, 2023

Nov 28, 2023, 8:30 AM EST - 1 year ago

Applied DNA Announces Receipt of Linea(TM) DNA Follow-On Order for Cancer Diagnostic Application

Nov 16, 2023, 8:30 AM EST - 1 year ago

Applied DNA Extends Application of Linea(TM) IVT Platform to saRNA (self-amplifying mRNA)

Nov 9, 2023, 9:15 AM EST - 1 year ago

Applied DNA Ships First saRNA (self-amplifying mRNA) IVT Template Generated by Linea(TM) DNA Platform

Sep 14, 2023, 9:00 AM EDT - 1 year ago

Applied DNA Partners with Cornell University College of Veterinary Medicine to Accelerate Development of Veterinary Vaccine Platform Targeting Diseases that Impact High-Value Animals

Sep 6, 2023, 9:00 AM EDT - 1 year ago

Applied DNA Advances Commercialization of Linea(TM) IVT Platform, Appoints Beverly Wolgast as Executive Director of Quality and cGMP Programs

Aug 29, 2023, 9:00 AM EDT - 1 year ago

Applied DNA Announces Availability and First Customer Shipment of New Linea(TM) IVT Evaluation Kit

Aug 23, 2023, 9:30 AM EDT - 1 year ago

Applied DNA Files Provisional Patent Applications for Methods of Double-Stranded RNA Mitigation in Next-Generation mRNA Production

Aug 12, 2023, 5:59 AM EDT - 1 year ago

Applied DNA Sciences, Inc. (APDN) Q3 2023 Earnings Call Transcript